There is growing evidence that cochlear implant recipients may benefit more from their devices if tonotopic mismatch is reduced. After providing an overview of recent research on tonotopic mismatch, this article explores how researchers and clinicians have been working to reduce tonotopic mismatch and improve hearing outcomes for MED-EL cochlear implant recipients.
Cochlear implantation has been shown to improve not only the hearing of thousands of patients with unilateral deafness, but growing evidence now shows that many SSD (single-sided deafness) CI (cochlear implant) users also benefit from improved tinnitus control, sound localization, and quality of life. This article summarizes key findings from recent publications, including systematic literature reviews, meta-analyses, and clinical considerations—that, for the first time, were able to draw on data from a large number of adult SSD-CI patients.
The Minimal Pairs Test may be able to reveal weaknesses in speech discrimination related to sounds that correspond with one or more frequency ranges. This information can be helpful for audiologists to help them identify which channels may need a closer look for adjustment as they program cochlear implants.
A bone conduction implant or an active middle ear implant? This is a common question in clinical treatment of mixed hearing loss, and there is considerable overlap in the indications for these two systems. But there are clear differences in how these two systems function—and, in some cases, also audiological results.
Introducing SONNET 3, our latest behind-the-ear audio processor, designed to maximize flexibility and freedom for MED-EL cochlear implant recipients and clinicians. To enhance wearing time, comfort, and everyday hearing enjoyment, SONNET 3 features integrated direct streaming, a convenient touch key, an optional flexible earhook, and is waterproof—all while providing users the closest to natural hearing with our smallest and lightest SONNET ever. To get the most out of SONNET 3 and Remote Care, our new MAESTRO 11 software is also here with a new look—but a familiar feel—to save you time when providing care.
A cochlear implant electrode serves not only as a crucial bridge between technology and nature that connects recipients to sound. The electrode array can significantly impact hearing outcomes. For instance, there is now growing consensus among researchers that stimulating more of the cochlea is associated with better speech perception and music appreciation. Here is the latest research you need to know to ensure each of your patients can benefit the most from their cochlear implant.
.png)
